Health Care & Life Sciences » Pharmaceuticals | ProPhase Labs Inc.

ProPhase Labs Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
25,032.00
22,070.00
20,604.00
4,206.00
9,867.00
13,126
Cost of Goods Sold (COGS) incl. D&A
8,361.00
7,891.00
8,426.00
3,209.00
7,919.00
8,345
Gross Income
16,671.00
14,179.00
12,178.00
997.00
1,948.00
4,781
SG&A Expense
16,255.00
18,430.00
15,762.00
4,791.00
5,938.00
6,415
EBIT
416.00
4,251.00
3,584.00
-
3,990.00
1,634
Unusual Expense
-
3,577.00
-
-
150.00
-
Non Operating Income/Expense
13.00
10.00
-
-
-
-
Interest Expense
-
-
18.00
213.00
54.00
-
Pretax Income
405.00
7,834.00
3,600.00
4,006.00
3,663.00
1,467
Income Tax
-
-
-
-
1,421.00
103
Consolidated Net Income
405.00
7,834.00
3,600.00
4,006.00
2,242.00
1,570
Net Income
405.00
7,834.00
3,600.00
4,006.00
2,242.00
1,570
Net Income After Extraordinaries
405.00
7,834.00
3,600.00
5,144.00
45,073.00
1,400
Net Income Available to Common
405.00
7,834.00
3,600.00
2,868.00
1,712.00
1,570
EPS (Basic)
0.03
0.47
0.22
0.17
2.61
0.15
Basic Shares Outstanding
15,839.00
16,773.00
16,398.00
17,081.00
15,565.00
11,396
EPS (Diluted)
0.02
0.47
0.22
0.17
2.61
0.15
Diluted Shares Outstanding
16,276.00
16,773.00
16,398.00
17,081.00
15,565.00
11,396
EBITDA
659.00
3,974.00
3,217.00
3,447.00
3,653.00
1,251
Non-Operating Interest Income
2.00
4.00
2.00
1.00
231.00
167

About ProPhase Labs

View Profile
Address
621 North Shady Retreat Road
Doylestown Pennsylvania 18901
United States
Employees -
Website http://www.prophaselabs.com
Updated 07/08/2019
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products, dietary supplements, and other remedies. Its products include TK supplement and Organix Rx. The company was founded by Guy J.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.